Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Surgery Partners (SGRY) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to 12.87%.

  • Surgery Partners' EBIT Margin rose 49600.0% to 12.87% in Q3 2025 from the same period last year, while for Sep 2025 it was 12.36%, marking a year-over-year increase of 15400.0%. This contributed to the annual value of 11.2% for FY2024, which is 7600.0% down from last year.
  • As of Q3 2025, Surgery Partners' EBIT Margin stood at 12.87%, which was up 49600.0% from 13.52% recorded in Q2 2025.
  • Over the past 5 years, Surgery Partners' EBIT Margin peaked at 18.81% during Q4 2021, and registered a low of 6.96% during Q1 2023.
  • Its 5-year average for EBIT Margin is 12.34%, with a median of 12.43% in 2022.
  • In the last 5 years, Surgery Partners' EBIT Margin soared by 76400bps in 2021 and then crashed by -98800bps in 2023.
  • Quarter analysis of 5 years shows Surgery Partners' EBIT Margin stood at 18.81% in 2021, then dropped by -29bps to 13.32% in 2022, then increased by 4bps to 13.79% in 2023, then grew by 7bps to 14.7% in 2024, then dropped by -12bps to 12.87% in 2025.
  • Its EBIT Margin was 12.87% in Q3 2025, compared to 13.52% in Q2 2025 and 7.98% in Q1 2025.